Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-035477
Filing Date
2022-11-10
Accepted
2022-11-10 08:30:11
Documents
1
Period of Report
2022-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7334
  Complete submission text file 0000899243-22-035477.txt   8657
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Deschatelets Pascal (Reporting) CIK: 0001657720 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 221375110